Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observational × HER2-positive Gastric Cancer × Clear all

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 460 Breast Neoplasms 426 Lung Neoplasms 234 Prostatic Neoplasms 207 Colorectal Neoplasms 198 Carcinoma, Non-Small-Cell Lung 174 Pancreatic Neoplasms 141 Carcinoma, Hepatocellular 126 Stomach Neoplasms 124 Ovarian Neoplasms 110 Esophageal Neoplasms 93 Head and Neck Neoplasms 91 Multiple Myeloma 87 Melanoma 86 Urinary Bladder Neoplasms 81 Uterine Cervical Neoplasms 77 Liver Neoplasms 74 Brain Neoplasms 74 Lymphoma 71 Endometrial Neoplasms 67 Hematologic Neoplasms 66 Disease 65 Rectal Neoplasms 62 Leukemia, Myeloid, Acute 60 Neoplasm Metastasis 59 Colonic Neoplasms 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 52 Leukemia 52 Carcinoma, Renal Cell 52 Thyroid Neoplasms 51

Interventions

trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06846996 2025-07-08

RECOVER

Daiichi Sankyo

Gastrointestinal

HER2-positive Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡